Tuberculosis infection and hypertension: Prevalence estimates from the US National Health and Nutrition Examination Survey

Argita D Salindri; Sara C Auld; Unjali P Gujral; Elaine M Urbina; Jason R Andrews; Moises A Huaman; Matthew J Magee

doi:10.1101/2023.05.12.23289899

Tuberculosis infection and hypertension: Prevalence estimates from the US National Health and Nutrition Examination Survey

medRxiv [Preprint]. 2023 May 16:2023.05.12.23289899. doi: 10.1101/2023.05.12.23289899.

Authors

Argita D Salindri¹, Sara C Auld^{2

3}, Unjali P Gujral⁴, Elaine M Urbina⁵, Jason R Andrews¹, Moises A Huaman⁶, Matthew J Magee^{3

4}

Affiliations

¹ Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
² Division of Pulmonary and Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, USA.
³ Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
⁴ Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
⁵ Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
⁶ Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Abstract

Objectives: Latent Tuberculosis infection (LTBI) is marked by dynamic host-pathogen interactions with persistent low-grade inflammation and is associated with increased risk of cardiovascular diseases (CVD) including acute coronary syndrome, myocardial infarction, and stroke. However, few studies assess the relationship between LTBI and hypertension, an intermediate of CVD. We sought to determine the association between LTBI and hypertension using data representative of the adult US population.

Methods: We performed cross-sectional analyses using data from the 2011-2012 US National Health and Nutrition Examination Survey (NHANES). Eligible participants included adults with valid QuantiFERON-TB Gold In-Tube (QFT-GIT) test results who also had blood pressure measures and no history of TB disease. LTBI was defined by a positive QFT-GIT. We defined hypertension by either elevated measured blood pressure levels (i.e., systolic ≥130mmHg or diastolic ≥80mmHg) or known hypertension indications (i.e., self-reported previous diagnosis or use of antihypertensive medications). Analyses were performed using robust quasi-Poisson regressions and accounted for the stratified probability sampling design of NHANES.

Results: The overall prevalence of LTBI was 5.7% (95%CI 4.7-6.7) and hypertension was present among 48.9% (95%CI 45.2-52.7) of participants. The prevalence of hypertension was higher among those with LTBI (58.5%, 95%CI 52.4-64.5) than those without LTBI (48.3%, 95%CI 44.5-52.1) (prevalence ratio [PR]=1.2, 95%CI 1.1-1.3). However, after adjusting for confounders, the prevalence of hypertension was similar for those with and without LTBI (adjusted PR=1.0, 95%CI 0.9 -1.1). Among individuals without CVD risk factors of elevated BMI (PR_{normal BMI}=1.6, 95%CI 1.2-2.0), hyperglycemia (PR_euglycemia=1.3, 95%CI 1.1-1.5), or cigarette smoking (PR_non-smokers=1.2, 95%CI 1.1-1.4), the unadjusted prevalence of hypertension was higher among those with LTBI vs. no LTBI.

Conclusions: More than half of adults with LTBI in the US had hypertension. Importantly, we observed a relationship between LTBI and hypertension among those without established CVD risk factors.

Keywords: hypertension; interferon-γ response; latent tuberculosis infection.

Publication types

Preprint

Abstract

Publication types

Grants and funding